Ultra Clean Holdings, Inc. Completes Strategic Merger with Advanced Integration Te... ( HAYWARD Calif. July 9 2012 /- Ul...)

Ultra Clean Holdings, Inc. Completes Strategic Merger with Advanced Integration Technologies

Date:7/9/2012

HAYWARD, Calif., July 9, 2012 /PRNewswire/ -- Ultra Clean Holdings, Inc. (Nasdaq: UCTT) a leading developer and supplier of critical subsystems for the semiconductor capital equipment, flat panel, medical, energy, and research industries today announced that it has completed the previously announced merger with Advanced Integration Technologies (AIT). AIT is recognized as a major supplier of critical subsystems and complete tools for the semiconductor capital equipment, medical device, and industrial equipment markets.

The merger benefits UCT in a number of strategic areas. The deal adds major new customers in the semiconductor capital equipment market and new customers in other markets, particularly medical equipment. It adds significant new capabilities to UCT in the manufacture of complete tools as well as adding frame manufacturing and sheet metal fabrication capabilities. The addition of AIT's revenue will significantly increase UCT's overall scale; in 2011 AIT had revenues of nearly $170M. The merger is expected to be accretive to earnings for the balance of 2012 and for all of 2013.

In addition, the move will leverage combined Asian manufacturing capabilities, support global expansion opportunities, and provide an enhanced customer value proposition through UCT's vertical integration model.

Advanced Integration Technologies is headquartered in Chandler, Arizona. With its high degree of vertical integration, which includes frame and sheet metal fabrication, AIT's capabilities span the entire spectrum of complex module and sub-system manufacturing, including advanced electro-mechanical systems integration as well as complete turnkey solutions. This vertical integration will enable UCT to design, engineer and manufacture complex products in a fashion that keeps costs down while improving quality and shortening order-to-delivery cycle times. With proven
'/>"/>

SOURCE Ultra Clean Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. MarketsandMarkets: Global Ultrasound Devices Market worth $8.1 Billion by 2017
2. AIUM and AUA Guideline Development Leads To Practice Accreditation For Urologic Ultrasound
3. UltraTape announces Cleanroom Labels for Cryogenic Laboratory applications
4. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
5. US HIFU to Showcase High Intensity Focused Ultrasound for the Treatment of Prostate Cancer at AUA
6. Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical - Global Trends & Competitive Analysis
7. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
8. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
9. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
10. Ultragenyx Relocates Company Headquarters to Support Operational Expansion
11. Clean Room Environmental Best Practices for Medical Device & Pharmaceutical Manufacturers are Focus of Boston Seminar on June 6

Post Your Comments:

(Date:5/21/2013)... N.Y., May 21, 2013 Lakeland Industries, Inc. ... manufacturer of industrial protective clothing for industry, municipalities, ... and local levels, today announced that the Company ... a Senior Credit Facility subject to certain terms ... this financing. However, no assurances can be given ...

(Date:5/21/2013)... CEO of Mammotome, a division of Devicor Medical Products, has ... Cincinnati chapter of the Association for Corporate Growth ... who is also a breast cancer survivor, led the purchase ... 2010. Daulton will be presented with the award at the ... May 22. The ACG Deal Maker Awards program ...

(Date:5/21/2013)... May 21, 2013 Kepner-Tregoe (KT), the ... that 13-year veteran Chris Geraghty ... experience includes more than 20 years serving the ... manufacturing organizations. He succeeds Ray Baxter ... Kepner-Tregoe,s Chairman of the Board and CEO. ...

[0] Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results [0] Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year [0] Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer

... ZURICH, July 16 An innovative treatment ... patients has received a second,orphan drug designation in ... was,granted. The recent designation relates to Burkholderia cepacia ... patients. For Axentis,Pharma AG of Zurich, Switzerland, both ...

... , BOSTON and EDISON, N.J., July ... with edoxaban(2) - an investigational oral Factor Xa inhibitor - ... receiving edoxaban once daily (QD) experienced fewer bleeding events than ... that bleeding associated with edoxaban is most closely correlated with ...

Cached Medicine Technology:Cystic Fibrosis - Liposomal Tobramycin Receives Second Orphan Drug Designation Within Weeks 2 Cystic Fibrosis - Liposomal Tobramycin Receives Second Orphan Drug Designation Within Weeks 3 Analysis of Edoxaban Phase II Data Provides Insight Into Reduced Bleeding Events Seen in Once-Daily Dosing 2 Analysis of Edoxaban Phase II Data Provides Insight Into Reduced Bleeding Events Seen in Once-Daily Dosing 3 Analysis of Edoxaban Phase II Data Provides Insight Into Reduced Bleeding Events Seen in Once-Daily Dosing 4 Analysis of Edoxaban Phase II Data Provides Insight Into Reduced Bleeding Events Seen in Once-Daily Dosing 5

Cystic Fibrosis - Liposomal Tobramycin Receives Second Orphan Drug Designation Within Weeks Analysis of Edoxaban Phase II Data Provides Insight Into Reduced Bleeding Events Seen in Once-Daily Dosing

(Date:5/21/2013)... May 21, 2013 ContinuCare Home Health, ... Department of Aging and Disability Services. After completing a ... interviews, ContinuCare Home Health was found to have ... is part of the Department of Aging and Disability ... and disability services, supports and opportunities that are ...

(Date:5/21/2013)... (PRWEB) May 21, 2013 Artisan ... EB-5 Investment Summit: Dealmakers Conference in Long Beach, ... will focus on exploring alternative finance through EB-5 ... latest market, legal and economic information, and updates ... legal professionals within the EB-5 industry. , ...

(Date:5/21/2013)... May 21, 2013 According to a May ... the Use of Botox,” Botox injections have become ... approval in 2002 (Go to goo.gl/8iYbD). Although it is mostly ... with men. The injection makes facial wrinkles less visible by ... last for about three months. This means that people who ...

(Date:5/21/2013)... Diversity Focus, a non-profit organization striving to improve ... the Creative Corridor region, is releasing results for its ... on Thursday, May 23rd at 10:30 a.m. The ... , The survey is a critical component to ... attract, nurture and retain people of diverse backgrounds, cultures ...

(Date:5/21/2013)... (May 21, 2013) A paper recently published in ... co-written by physicians and scientists at the University of ... risk factor for pulmonary fibrosis can be used to ... , Researchers looked at a fairly common variant of ... component of the mucous produced by the bronchial tubes. ...

Breaking Medicine News(10 mins):Health News:ContinuCare Home Health, Inc. Receives Perfect Report from the Texas Department of Aging and Disability Services 2 Health News:Artisan Business Group to Host EB-5 Investment Conference in Long Beach, California 2 Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2 Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2 Health News:Researchers find genetic risk factor for pulmonary fibrosis 2

[0] ContinuCare Home Health, Inc. Receives Perfect Report from the Texas Department of Aging and Disability Services [0] Artisan Business Group to Host EB-5 Investment Conference in Long Beach, California [0] Botox – Is the World’s Most Popular Cosmetic Procedure Safe?[0] Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m.[0] Researchers find genetic risk factor for pulmonary fibrosis

... Boston Scientific,Corporation (NYSE: BSX ) today announced ... ALTRUA(TM) family of pacemakers. ALTRUA is Boston,Scientific,s most ... small size and battery longevity. It is the ... in which the,heart beats too slowly -- usually ...

... Inc.,("GNC" or the "Company"), the largest global specialty ... for the first,quarter ended March 31, 2008., ... of GNC Parent LLC,which was acquired on March ... and Ontario Teachers, Pension Plan Board ("Teachers"). As ...

... Alimera Sciences Inc., a privately held,ophthalmic pharmaceutical ... pilot study to assess the safety and efficacy ... Genentech) in patients,with exudative age-related macular degeneration (wet ... performed under an investigator,sponsored IND, will compare two ...

... Market Share in Europe and Canada; ... LAVAL, QC, May 8 /PRNewswire-FirstCall/ - Labopharm Inc. ... first quarter ended March,31, 2008. All figures are in ... to make strong progress in the global,commercialization of our ...

... Appeals for More than $8 million for medicines and other lifesaving ... ... As the death toll from,Cyclone Nargis climbs steeply, UNICEF is gravely ... sanitary conditions,could significantly increase the death toll among children and other,vulnerable populations, ...

... Inc. ("Holdings",or the "Company"), the parent company of ... largest cancer services companies, reported revenue of,$810.6 million, ... flow of,$50.9 million for the quarter ended March ... those of US Oncology, its wholly-owned,subsidiary, through which ...

Boston Scientific Announces FDA Approval of New Family of Advanced Pacemakers General Nutrition Centers, Inc. Reports First Quarter 2008 Financial Results Pilot Study to Assess Safety and Efficacy of Medidur(TM) FA in AMD Patients Treated With Lucentis(R)Labopharm Reports Results for First Quarter Fiscal 2008 Myanmar Cyclone a Children's Catastrophe - UNICEF US Oncology Reports First Quarter 2008 Results

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

Medicine Products:

Pelvic Washing for Cytology PBG, Urine Quantitative Parvovirus B19 Antibody, IgM Parvovirus B 19, by PCR, Bone Marrow